MedTrace Logo

Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma

NCT01836484 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 162

Last updated 2020-02-13

No results posted yet for this study

Summary

This is a prospective diagnostic performance study which compares three new imaging methods with the current standard imaging method for the diagnosis of metastatic lymph nodes.

Conditions

  • Surgically Staged Endometrial and Cervical Carcinoma
  • Cervical Cancer: Invasive Disease, FIGO Stage 1B1 or Higher
  • Endometrial Cancer
  • Stage 1A With Myometrial Invasion or Any Higher Stage and Grade 3
  • Stage 1A With Myometrial Invasion or Any Other Higher Stage and Serous Papillary or Clear Cell Sub-types
  • Stage II Disease or Above and Any Histology Grade

Interventions

DIAGNOSTIC_TEST

Diffusion-weighted MRI

DIAGNOSTIC_TEST

Fluorodeoxyglucose-18-PET/CT

DIAGNOSTIC_TEST

Fluoro-ethyl-coline-PET/CT

Sponsors & Collaborators

  • Birmingham Women's NHS Foundation Trust

    collaborator OTHER_GOV

  • Case Western Reserve University

    collaborator OTHER

  • Guy's and St Thomas' NHS Foundation Trust

    collaborator OTHER

  • Hammersmith Hospitals NHS Trust

    collaborator OTHER

  • Memorial Sloan-Kettering Cancer Center, USA

    collaborator UNKNOWN

  • Queen Elizabeth Hospital, Gateshead, UK

    collaborator UNKNOWN

  • Royal Preston Hospital, Lancashire, UK

    collaborator UNKNOWN

  • Royal Marsden NHS Foundation Trust

    collaborator OTHER

  • University of Birmingham

    collaborator OTHER

  • Barts & The London NHS Trust

    lead OTHER

Principal Investigators

  • Andrea Rockall, Professor · Imperial College Healthcare NHS Trust

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01836484 on ClinicalTrials.gov